EuropaBio Press release: New Study on HTA Processes
A new report on Health Technology Assessment (HTA) processes published today highlights significant areas for improvement in order to accelerate patients’ access to new technologies and innovative medicines, and to make the most of tight public budgets. The study, jointly commissioned by EFPIA, EuropaBio, Medicines Australia and PhRMA, compares the HTA processes and outputs against best practice principles.
Go to the report summary.
Go to the full report.
Go to EuropaBio Press Release: New Study on HTA Processes Highlights Areas for Improvement to Accelerate Patients’ Access to Innovative Medicines.